Italy drugmaker Zambon ready to splash out in U.S., China push

Italian drugmaker Zambon is looking to China and the U.S. to grow its respiratory and nervous system portfolio and could spend more than 100 million euros ($114 million) on the right acquisition, its chief executive said.

from Reuters: Health News https://reut.rs/2sItiIp